Agenda :
 

Tuesday, March 18th

6:00-8:00 pm Registration, cocktail and Dinner reception
Hosted by: Palo Alto Investors
Wednesday, March 19th
7:00-8:30 am

Registration & Continental Breakfast

   
8:30-9:00 am

Chairman’s Welcome & Opening Remarks

  Jim Glasheen, General Partner – Technology Partners
   
9:00-10:00 am Kick-Off Keynote Presentation
  Consumer Medicine: Is it part of the solution for what ails the US Healthcare system?
  A public policy perspective.
  Dr. Mark B. McClellan, former administrator for the Centers for Medicare and Medicaid Services (CMS) and former commissioner of the Food and Drug Administration (FDA) in the U.S. Department of Health and Human Services
   
10:00-10:30 am

Networking Break
Hosted by: Procter & Gamble Pharmaceuticals

   
10:30-11:30 am

Regulatory Hurdles: Friend or Foe?

 

• What are the implications of bringing regulatory oversight into an arena that has    historically been lightly regulated?
• How important is label language in the consumer market?
• What are the key success factors in moving from and Rx to OTC environment?
• How do you manage safety concerns in lifestyle indications?

   
  MODERATOR:
  Camille Samuels, Managing Director – Versant Ventures
   
 

PANELISTS:

 

Tad Simons , IDEO
Keith Leonard,
CEOKythera BioPharmaceuticals
Lynne Millheiser
, CEO – Dynova
Nick Teti, Chairman – Isolagen

   
11:30 – 12:30 pm Understanding the Patient as Consumer (PaC) and its Implications for Product Development
  • How do you develop distinctive consumer insights into the (PaC)?
• How do you integrate consumer insight into the very earliest stages of product    development?
• What is different about designing a product driven by consumer preference vs.    professional preference?
   
  MODERATOR:
  Nina Kjellson, Partner – Interwest Partners
   
 

PANELISTS:

  Mari Baker, CEO – Navigenics
Mitch Pergola,
Managing Partner - Fuseproject
Kevin Driscoll,
Director – Procter & Gamble Pharmaceuticals
Chris Hacker
,
Chief Design Officer - Johnson & Johnson
   
12:30 – 2:30 pm Luncheon with Speaker
 
FIRESIDECHAT  
Interviewer:  
Steve Elms
General Partner
Aisling Capital
 
  Martek: Overcoming the challenges as a pioneering consumer biotech company
 
Guest Speaker:  

Steve Dubin
CEO
Martek

 
   
2:30 – 3:30 pm Beyond the Great Idea…How to Finance & Grow Your Consumer Medicine Company
  • What is the public market appetite for Consumer Medicine companies? How are they   valued and what are the criteria for an IPO?
• What is the M&A environment? Are large pharma and major medtech turning their    attention to this area?
• What areas capture VC interest and how is it changing?
• Money is only part of the equation. What are the issues and opportunities associated    with attracting talented people to Consumer Medicine companies?
   
  MODERATOR:
  Albert Cha, Managing Partner – Vivo Ventures
   
 

PANELISTS:

  Steve Basta, CEO – BioForm Medical, Inc.
Louis Klevan,
Managing Director – BMO Capital Markets
Will Rosenzweig,
Managing Director – Physic Ventures
Ken Trbovich
, Analyst – RBC Capital Markets
   
3:30 – 4:30 pm The Role of the Channel in Consumer-Driven Markets. Why You Need to Think Differently from Traditional Professionally-Driven Markets.
 

• What channels are effective at differentiating product quality?
• How can you effectively engage both a professional channel and consumer channel    simultaneously?
• Where can the conflicts arise?
• How are channel decisions changing?
• What trends or lessons can be applied in the US from other markets/regions? Where are    there hot spots of developing opportunity?
• Is “partnering” real or a four letter word?

   
  MODERATOR:
  Ted Janus, Partner – Palo Alto Investors
   
 

PANELISTS:

 

Robert Grant, President – Allergan Medical
Robert Grove
, CEO – Spectragenics
Jeff Nugent, CEO – Ventus Medical
Steve Osbaldeston, CEO – Ophthonix
Jean-Michel Valette, Chairman – Peet’s Coffee

   
4:30 – 5:00 pm Networking Break
Hosted by:Procter & Gamble Pharmaceuticals
   
5:00 – 5:45 pm Closing Keynote:
  Building the Brand at Adams: Mucinex In, Competitors Out.
  Mike Valentino,
CEO
Adams Respiratory
   
   
5:45 – 6:00 pm Wrap-Up
  Wrap-up of key themes that came out of the day’s discussions and implications for breakfast roundtable / thought-leader sessions for the next morning.
   
6:00 – 7:00 pm Cocktail Reception
Hosted by: Bioquest, LLC
   
7:00 - 9.00 pm Gala Dinner & Entertainment
Hosted By: Alexandria Real Estate Equities
   
9:00-11:00 pm

VIVA LAS VEGAS Casino Party
Hosted by: BMO Capital Markets

   

Thursday, March 20th

9:00-11:00 am Breakfast Roundtable Discussions:
Based on hot issues raised during Wednesday’s general session’s
   
  Roundtable Leaders:
  Ted Janus, Partner - Palo Alto Investors
Vic Narurkar, Founder - Bay Area Laser Institute
Jeff Nugent, CEO – Ventus Medical
Jean-Michel Valette, Chairman – Peet’s Coffee and Tea
Joon Yun, Partner - Palo Alto Investors
   
  Specific topics to be selected based on key interests of the conference participants.  Potential topics include:
   
  • Issues affecting the future regulatory environment for consumer medicine
• Discretionary spending in a recession…what it means for consumer medicine
• Consumer Medicine from a provider perspective
• Darwinian Consumerism…ensuring that your product is the fittest
   
11:00 am Summit Adjourns

 

 

Home | Agenda | Advisory Board | Sponsors | Speakers | Hotel | Register | Contacts
© 2007 International Business Forum. All Rights Reserved.